|
WARNING!
Our banking details have not changed – another fraud attempt
The attached letter is another example of attempts to illegally extract funds. Should you receive any advice on changes to banking details please contact Regan Kruger – Private Pharma Channel Manager on:
+2782 306 9669
or Charles Campbell National Security Manager on:
+2779 495 2028
immediately to verify the integrity of the advice. | |
|
|
|
|
|
|
 |
| |
| UTi Pharma makes sure people everywhere have the medicine and healthcare products they need to keep them well. UTi Pharma doesn't make medicine but its systems, technology, a global and local web of pharma grade warehouse facilities, fleet of vehicles, and passionate people make sure that patients always get the original quality medicine they need, when and where they need it. UTi Pharma has developed its business hand-in-hand with many of today's leading pharmaceutical companies, providing them - and millions of patients - with value-for-money, accessible and reliable healthcare. |
| |
 |
| |
| The Pharmacy Advisory Forum connects manufacturers, UTi Pharma and community pharmacist across a range of projects designed to deliver accessible and affordable healthcare to all South Africans. For more… |
| |
 |
| |
| ePharmaC is an online community of pharmacists, empowered by UTi Pharma through the Pharmacy Advisory Forum, that aims to facilitate communication and education among community pharmacists. For more... |
| |
 |
| |
| Lifetime learning via the internet – through CECENTRE – is here! This unique product supports the healthcare professional in his or her Continuous Professional Development (CPD), Performance Improvement (PI), & Lifelong Learning. CECENTRE has been made possible by UTi Pharma and the Pharmacy Advisory Forum, and will be available through ePharmaC. |
| |
 |
| |
| Novo Nordisk joins UTi Pharma on 1 February 2010. Novo Nordisk has 41 product lines consisting mainly of insulin and hormone replacement therapy products. Sales to customers in the Export, State, State Export and Wholesale market segments will be direct from Novo Nordisk. As an innovation, the Novo Nordisk stock will be available to Pharmacies from UTi Pharma. A background process will occur when the order is placed requiring no action on the part of the pharmacy, and the Novo Nordisk products will appear on invoices supplied as belonging to the UTi Pharma division. |
|
|
|
|
|
|
|
|